# Cipla Limited - Inspection Records

Source: https://www.keypedia.com/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb

> Inspection records and compliance data for Cipla Limited in Bengaluru, None. Access full analysis and detailed observations.

---

## Details

- Name: Cipla Limited
- FEI Number: 3002806691
- City: Bengaluru
- State: None
- Country Name: India
- Address Line 1: Old Madras Road
- Zip Code: None
- Facility Type: API Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Cipla Limited - 2024-11-13](https://www.keypedia.com/records/483/cipla-limited/53061bbf-ca16-42ce-b780-25e91280d57b) — source: FDA, date: November 13, 2024
- [FDA Inspection 1254500 - Cipla Limited - 2024-11-13](https://www.keypedia.com/records/fda_inspections/cipla-limited/951ba987-ff08-4cf0-a68e-c3e82cccd492) — source: FDA, date: November 13, 2024
- [FDA Inspection 1254500 - Cipla Limited - 2024-11-13](https://www.keypedia.com/records/fda_inspections/cipla-limited/50c6a772-2a7d-43d4-abfc-11aa6d3bc960) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 13, 2024
- [FDA Inspection 1160347 - Cipla Limited - 2020-01-31](https://www.keypedia.com/records/fda_inspections/cipla-limited/ff4028a6-ce64-4e10-9778-77c6252b51de) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2020
- [483 - Cipla Limited - 2019-07-19](https://www.keypedia.com/records/483/cipla-limited/3f8bbc67-313f-4442-bdc2-7deda4dfa0a7) — source: FDA, date: July 19, 2019
- [483 - Cipla Limited - 2019-07-19](https://www.keypedia.com/records/483/cipla-limited/024e48d2-35ef-49f9-ad8b-e77be6e252e9) — source: FDA, date: July 19, 2019
- [FDA Inspection 1099619 - Cipla Limited - 2019-07-19](https://www.keypedia.com/records/fda_inspections/cipla-limited/87069a20-8238-4cd8-bfc5-d14eaee4db66) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2019
- [FDA Inspection 1009388 - Cipla Limited - 2017-04-05](https://www.keypedia.com/records/fda_inspections/cipla-limited/46b2399d-6408-40cd-82ae-4d8aac71506d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2017
- [FDA Inspection 891868 - Cipla Limited - 2014-07-25](https://www.keypedia.com/records/fda_inspections/cipla-limited/77a61b51-34a6-439b-9d5e-906b15609e28) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2014
- [FDA Inspection 790473 - Cipla Limited - 2012-06-28](https://www.keypedia.com/records/fda_inspections/cipla-limited/45321fb4-6a50-409c-b930-de580b6b9a6c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2012
- [FDA Inspection 577409 - Cipla Limited - 2009-04-09](https://www.keypedia.com/records/fda_inspections/cipla-limited/afd00d05-8c7d-44f0-98b5-4237bc987099) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2009

## Related Companies

- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [Sumitomo Chemical Co., Ltd.](https://www.keypedia.com/companies/sumitomo-chemical-co-ltd/3ce10d51-6999-467f-ac0e-cb6696a98aa5)
- [Cambrex Profarmaco Milano Srl](https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef)
- [Divi's Laboratories Ltd. (Unit II)](https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf)
- [University of Missouri - Columbia Research Reactor Center](https://www.keypedia.com/companies/university-of-missouri-columbia-research-reactor-center/8b52f6ac-83c0-4557-834e-e421d6114e0b)
- [Matrix Pharmacorp Private Limited](https://www.keypedia.com/companies/matrix-pharmacorp-private-limited/3cbdd9ae-291e-406d-9e2c-5479410bf998)
- [Pfizer Asia Manufacturing Pte Ltd.](https://www.keypedia.com/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [Eisai Co., Ltd. Kashima Plant](https://www.keypedia.com/companies/eisai-co-ltd-kashima-plant/70a3ccaf-c591-4ebf-952a-a2ee6a62e53c)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/b3bdc4a2-a966-484a-9ac4-f4715912e6e2)

## Related Officers

- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)
- [Ralph H. Vocque](https://www.keypedia.com/people/ralph-h-vocque/dfd4e4f2-b03d-44ec-9dd7-7edcee303356)
- [Investigator](https://www.keypedia.com/people/kellia-n-hicks/44104c4a-70c1-47fc-9a77-c09c41bacc2b)
- [Investigator](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)